Dihydroartemisinin Inhibits Angiogenesis in Breast Cancer via Suppressing NF-κB/MMP-2/-9 Pathway
Qi Rao(Huanggang Central Hospital), Fenghua Wu(Hubei University of Chinese Medicine), Yu He(Southern University of Science and Technology), Xiaohong Guo(University of Medical Sciences and Technology), Yuxue Wang(Southwest University), Gang Zhao(Union Hospital), Ruochan Li(Hubei University of Chinese Medicine), Bin He(Blood Center of Zhejiang Province)
Cited by 2
Related Papers
MiR-130b Is a Prognostic Marker and Inhibits Cell Proliferation and Invasion in Pancreatic Cancer through Targeting STAT3
|PLoS ONE|2013|125
Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein
|Theranostics|2019|106
Hypoxia-induced lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR-3923/KRAS pathway
|Oncotarget|2016|104
MiR-548an, Transcriptionally Downregulated by HIF1α/HDAC1, Suppresses Tumorigenesis of Pancreatic Cancer by Targeting Vimentin Expression
|Molecular Cancer Therapeutics|2016|63
The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction
|International Journal of Biological Sciences|2018|45